All episodes

Ep. 51: Gut microbiota and neurodegenerative diseases

Ep. 51: Gut microbiota and neurodegenerative diseases

26m 32s

Moderator: Kristian Steen Frederiksen (Copenhagen, Denmark)

Guest: Svetlana Tomic (Osijek, Croatia)

In this second episode, Moderator Kristian Steen Frederiksen is joined by Prof. Svetlana Tomic to talk about gut microbiota in context with neurodegenerative diseases.

Ep. 50: Muscle hyperexcitability complaints

Ep. 50: Muscle hyperexcitability complaints

28m 25s

Moderator: Kristian Steen Frederiksen (Copenhagen, Denmark)

Guest: Lutz Fröhlich (Mannheim, Germany)

The field of dementia and specifically the treatment of Alzheimer´s disease is at the brink of a possible new era in which disease-modifying therapy will become available in the form of anti-bodies directed against beta-amyloid.

Prof. Kristian Steen Frederiksen and Prof. Lutz Fröhlich kick off the June episodes on Dementia and Cognitive Disorderswith discussions on the background and development of anti-bodies directed against beta-amyloid development, status with regards to clinical trials in AD of anti-amyloid anti-body therapy, and challenges and opportunities in clinical practice if anti-amyloid anti-body therapy will...

Ep. 49: EAN-WFN Joint Initiatives

Ep. 49: EAN-WFN Joint Initiatives

32m 26s

Moderator: Thomas Berger (Vienna, Austria)

Guest: Wolfgang Grisold (Vienna, Austria)

Prof. Thomas Berger is joined by Prof. Wolfgang Grisold, the current president of the World Federation of Neurology, to discuss brain health, global neurological topics, and joint initiatives between EAN and the WFN.

Ep. 48: Treatment outcome measures of Pompe’s disease

Ep. 48: Treatment outcome measures of Pompe’s disease

25m 19s

Moderator: Anna Kostera-Pruszczyk (Warsaw, Poland)

Guest: Antonio Toscano (Messina, Italy)

For the final episode of the month on Muscle and Neuro-muscular Junction disorders,     Prof. Pruszczyk discusses Pompe’s Disease with Prof. Antonio Toscano.

Ep. 47: Genetic testing and counseling

Ep. 47: Genetic testing and counseling

27m 36s

Moderator: Anna Kostera-Pruszczyk (Warsaw, Poland)
Guest: Maria J. Molnar (Budapest, Hungary), Massimiliano Filosto (Gussago Brescia, Italy)
For this episode, Anna Kostera-Pruszczyk is joined by Prof. Maria J. Molnar and Prof. Massimiliano Filosto to discuss the Pros and Cons of genetic testing and counselling.

Ep. 46: Dilemmas for myasthenia gravis emerging therapies

Ep. 46: Dilemmas for myasthenia gravis emerging therapies

19m 12s

Moderator: Anna Kostera-Pruszczyk (Warsaw, Poland)
Guest: Nicolas Dubuisson (Brussels, Belgium), Amelia Evoli (Rome, Italy)
In this second episode specialist moderator Prof. Anna Kostera-Pruszczyk is joined by Dr. Nicolas Dubuisson and Prof. Amelia Evoli to discuss dilemmas for myasthenia gravis emerging therapies.

Ep. 45: Muscle hyperexcitability complaints

Ep. 45: Muscle hyperexcitability complaints

20m 0s

Moderator: Anna Kostera-Pruszczyk (Warsaw, Poland)

Guest: Federica Montagnese  (Messina, Italy)

To start off this months podcasts on Muscle and neuromuscular junction disorders, specialist moderator Prof. Anna Kostera-Pruszczyk is joined by Dr. Federica Montagnese to discuss muscle hyperexcitability.

Ep. 44: Imaging after a first seizure

Ep. 44: Imaging after a first seizure

22m 47s

Moderator: Prof. Bogdan Draganski (Lausanne, Switzerland)
Guest: Prof. Margitta Seeck (Geneva, Switzerland)
To end this month’s podcast topic of Neuroimaging, specialist moderator Prof. Bogdan Draganski is joined by Margitta Seeck, Professor of Epileptology, to discuss the various steps regarding imaging after a first epileptic seizure.

Ep. 43: Indications for neuroimaging in acute care

Ep. 43: Indications for neuroimaging in acute care

27m 38s

Moderator: Prof. Bogdan Draganski (Lausanne, Switzerland)
Guest: Prof. Roland Wiest (Bern, Switzerland)
For the third week of our April episodes on Neuroimaging, specialist moderator Prof. Bogdan Draganski from Switzerland is joined by Roland Wiest, Professor for Advanced Neuroimaging, to discuss the indications for neuroimaging in acute care.